A comparison of 2-amino-4-phosphonobutyric acid (AP4) receptors and [3H]AP4 binding sites in the rat brain

Richard J. Bridges, Tim J. Hearn, Daniel T Monaghan, Carl W. Cotman

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The glutamate analogue 2-amino-4-phosphonobutyric acid (AP4) is a potent antagonist at several synapses where an excitatory amino acid appears to be the neurotransmitter. Previous studies identified a Cl-/Ca2+ dependent [3H]glutamate binding site in synaptic plasma membrane (SPM) preparations that was also labeled by [3H]AP4 and exhibited a pharmacology similar to the AP4 receptor. This report examines the pharmacological specificity in both biochemical and electrophysiological preparations in greater detail. Several compounds are identified which readily interact with the apparent binding site in membranes, but neither mimic nor inhibit the action of AP4 in electrophysiological studies. The rate of dissociation of [3H]AP4 from SPMs is shown to increase in the presence of added AP4 and increasing the osmolarity in the SPM binding assay decreases the level of observed [3H]AP4 binding. These finding indicate both a heterogenous population of binding sites and the occurrence of transport. It is concluded that much of the AP4 binding observed in SPM preparations is to a site other than the AP4 receptor. The results provide a further pharmacological description of AP4 receptors which should facilitate the identification of the receptor in biochemical preparations.

Original languageEnglish (US)
Pages (from-to)204-209
Number of pages6
JournalBrain Research
Volume375
Issue number1
DOIs
StatePublished - Jun 4 1986

Fingerprint

Synaptic Membranes
Binding Sites
Cell Membrane
Pharmacology
Glutamic Acid
Brain
Excitatory Amino Acids
Synapses
Osmolar Concentration
Neurotransmitter Agents
Membranes
Population
2-amino-4-phosphonobutanoic acid receptor
2-amino-4-phosphonobutyric acid

Keywords

  • 2-amino-4-phosphonobutyric acid (AP4) receptor
  • glutamate binding
  • glutamate receptor
  • glutamate uptake
  • lateral perforant path

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

A comparison of 2-amino-4-phosphonobutyric acid (AP4) receptors and [3H]AP4 binding sites in the rat brain. / Bridges, Richard J.; Hearn, Tim J.; Monaghan, Daniel T; Cotman, Carl W.

In: Brain Research, Vol. 375, No. 1, 04.06.1986, p. 204-209.

Research output: Contribution to journalArticle

Bridges, Richard J. ; Hearn, Tim J. ; Monaghan, Daniel T ; Cotman, Carl W. / A comparison of 2-amino-4-phosphonobutyric acid (AP4) receptors and [3H]AP4 binding sites in the rat brain. In: Brain Research. 1986 ; Vol. 375, No. 1. pp. 204-209.
@article{b4800db7cd6d405ab86abc2980606288,
title = "A comparison of 2-amino-4-phosphonobutyric acid (AP4) receptors and [3H]AP4 binding sites in the rat brain",
abstract = "The glutamate analogue 2-amino-4-phosphonobutyric acid (AP4) is a potent antagonist at several synapses where an excitatory amino acid appears to be the neurotransmitter. Previous studies identified a Cl-/Ca2+ dependent [3H]glutamate binding site in synaptic plasma membrane (SPM) preparations that was also labeled by [3H]AP4 and exhibited a pharmacology similar to the AP4 receptor. This report examines the pharmacological specificity in both biochemical and electrophysiological preparations in greater detail. Several compounds are identified which readily interact with the apparent binding site in membranes, but neither mimic nor inhibit the action of AP4 in electrophysiological studies. The rate of dissociation of [3H]AP4 from SPMs is shown to increase in the presence of added AP4 and increasing the osmolarity in the SPM binding assay decreases the level of observed [3H]AP4 binding. These finding indicate both a heterogenous population of binding sites and the occurrence of transport. It is concluded that much of the AP4 binding observed in SPM preparations is to a site other than the AP4 receptor. The results provide a further pharmacological description of AP4 receptors which should facilitate the identification of the receptor in biochemical preparations.",
keywords = "2-amino-4-phosphonobutyric acid (AP4) receptor, glutamate binding, glutamate receptor, glutamate uptake, lateral perforant path",
author = "Bridges, {Richard J.} and Hearn, {Tim J.} and Monaghan, {Daniel T} and Cotman, {Carl W.}",
year = "1986",
month = "6",
day = "4",
doi = "10.1016/0006-8993(86)90977-7",
language = "English (US)",
volume = "375",
pages = "204--209",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - A comparison of 2-amino-4-phosphonobutyric acid (AP4) receptors and [3H]AP4 binding sites in the rat brain

AU - Bridges, Richard J.

AU - Hearn, Tim J.

AU - Monaghan, Daniel T

AU - Cotman, Carl W.

PY - 1986/6/4

Y1 - 1986/6/4

N2 - The glutamate analogue 2-amino-4-phosphonobutyric acid (AP4) is a potent antagonist at several synapses where an excitatory amino acid appears to be the neurotransmitter. Previous studies identified a Cl-/Ca2+ dependent [3H]glutamate binding site in synaptic plasma membrane (SPM) preparations that was also labeled by [3H]AP4 and exhibited a pharmacology similar to the AP4 receptor. This report examines the pharmacological specificity in both biochemical and electrophysiological preparations in greater detail. Several compounds are identified which readily interact with the apparent binding site in membranes, but neither mimic nor inhibit the action of AP4 in electrophysiological studies. The rate of dissociation of [3H]AP4 from SPMs is shown to increase in the presence of added AP4 and increasing the osmolarity in the SPM binding assay decreases the level of observed [3H]AP4 binding. These finding indicate both a heterogenous population of binding sites and the occurrence of transport. It is concluded that much of the AP4 binding observed in SPM preparations is to a site other than the AP4 receptor. The results provide a further pharmacological description of AP4 receptors which should facilitate the identification of the receptor in biochemical preparations.

AB - The glutamate analogue 2-amino-4-phosphonobutyric acid (AP4) is a potent antagonist at several synapses where an excitatory amino acid appears to be the neurotransmitter. Previous studies identified a Cl-/Ca2+ dependent [3H]glutamate binding site in synaptic plasma membrane (SPM) preparations that was also labeled by [3H]AP4 and exhibited a pharmacology similar to the AP4 receptor. This report examines the pharmacological specificity in both biochemical and electrophysiological preparations in greater detail. Several compounds are identified which readily interact with the apparent binding site in membranes, but neither mimic nor inhibit the action of AP4 in electrophysiological studies. The rate of dissociation of [3H]AP4 from SPMs is shown to increase in the presence of added AP4 and increasing the osmolarity in the SPM binding assay decreases the level of observed [3H]AP4 binding. These finding indicate both a heterogenous population of binding sites and the occurrence of transport. It is concluded that much of the AP4 binding observed in SPM preparations is to a site other than the AP4 receptor. The results provide a further pharmacological description of AP4 receptors which should facilitate the identification of the receptor in biochemical preparations.

KW - 2-amino-4-phosphonobutyric acid (AP4) receptor

KW - glutamate binding

KW - glutamate receptor

KW - glutamate uptake

KW - lateral perforant path

UR - http://www.scopus.com/inward/record.url?scp=0022650273&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022650273&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(86)90977-7

DO - 10.1016/0006-8993(86)90977-7

M3 - Article

VL - 375

SP - 204

EP - 209

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -